HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer.

AuthorsPeter Nygren, Rolf Larsson
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 53 Issue 3 Pg. 427-8 (Mar 2014) ISSN: 1651-226X [Electronic] England
PMID24160353 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Mebendazole
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Colonic Neoplasms (drug therapy, pathology)
  • Drug Repositioning
  • Humans
  • Liver (drug effects, enzymology)
  • Male
  • Mebendazole (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: